Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19.
Kasugai D, Tanaka T, Suzuki T, Ito Y, Nishida K, Ozaki M, Kutsuna T, Yokoyama T, Kaneko H, Ogata R, Matsui R, Goshima T, Hamada H, Ishii A, Kodama Y, Jingushi N, Ishikura K, Kamidani R, Tada M, Okada H, Yamamoto T, Goto Y.
Kasugai D, et al. Among authors: goshima t.
Front Immunol. 2024 Mar 11;15:1337070. doi: 10.3389/fimmu.2024.1337070. eCollection 2024.
Front Immunol. 2024.
PMID: 38529277
Free PMC article.